Treatment of children with congenital heart disease and growth retardation with recombinant human growth hormone
Authors:
- 1 February 1996
- journal article
- case report
- Published by Wiley in Acta Paediatrica
- Vol. 85 (2) , 251-253
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled studyThe Journal of Pediatrics, 1994
- Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapyThe Journal of Pediatrics, 1993
- Early surgical closure of a large ventricular septal defect: Influence on long-term growthJACC, 1991
- Redistribution of Regional Blood Flow and Oxygen Delivery in Experimental Cyanotic Heart Disease in Newborn LambsPediatric Research, 1987
- Why does congenital heart disease cause failure to thrive?Archives of Disease in Childhood, 1985
- Delay in Bone Age in Children with Cyanotic Congenital Heart DiseaseRadiology, 1973
- Alteration of Glucose and Insulin Metabolism in Congenital Heart DiseaseCirculation, 1972
- Pulmonary artery banding in isolated or complicated ventricular septal defects. Results and effects on growth.Heart, 1972
- Hypoxia and malnutrition in newborn rats: effects on RNA, DNA, and protein in tissuesAmerican Journal of Physiology-Legacy Content, 1969
- Growth in children with congenital heart diseaseThe Journal of Pediatrics, 1967